Immucell Corp (ICCC) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	478.16K
Depreciation	569.08K
Amortization	21.68K
Deferred income taxes
Stock-based compensation	50.31K
Loss on disposal of fixed assets
Receivables
Inventory	-783.19K
Prepaid expenses and other assets	-471.03K
Accrued expenses
Accounts payable
Deferred revenue	33.86K
Net cash provided by (used for) operating activities	48.14K
Purchase of property, plant and equipment	-1.79M
Maturities of short-term investments	3.97M
Purchases of short-term investments	-4.22M
Net cash (used for) provided by investing activities	-2.41M
Proceeds from debt issuance	0
Debt principal repayments	-100.55K
Proceeds from exercise of stock options	31.98K
Tax benefits related to stock options
Net cash provided by financing activities	5.2M
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	2.84M
BEGINNING CASH AND CASH EQUIVALENTS	1.57M
ENDING CASH AND CASH EQUIVALENTS	4.41M
INTEREST EXPENSE PAID	115.68K
INCOME TAXES PAID	125.13K
Change in capital expenditures included in accounts payable	163.64K
Decrease in fair value of interest rate swap, net of taxes

Entities mentioned with ICCC

View All Entities